日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Hepatic arterial infusion chemotherapy plus sintilimab as conversion therapy for locally advanced hepatocellular carcinoma: a single-center phase II trial

肝动脉灌注化疗联合信迪利单抗作为局部晚期肝细胞癌的转化治疗：一项单中心II期试验

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000004692
Pan, Yangxun; Wang, Xiaohui; Peng, Chuan; Zhao, Jing; Lu, Shixun; Zhang, Chao; Wang, Juncheng; Fu, Yizhen; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun; Xu, Li
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

更正：肿瘤周围肝细胞中的YTHDF2通过CX3CL1介导的CD8+ T细胞募集来介导化疗诱导的抗肿瘤免疫反应。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02252-7
Yang, Zhenyun; Wang, Xin; Fu, Yizhen; Wu, Weijie; Hu, Zili; Lin, Qingyang; Peng, Wei; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Zhou, Zhongguo; Xu, Li; Zhang, Yaojun; Hou, Jiajie; Chen, Minshan
肿瘤
T细胞
肿瘤免疫
CX3CL1
CD8
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study

肝动脉灌注化疗联合靶向治疗和免疫治疗与全身化疗治疗晚期肝内胆管癌的疗效比较：一项回顾性队列研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000002013
Zheng, Zhikai; Wang, Jiongliang; Wu, Tianqing; He, Minrui; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Xu, Li; Zhang, Yaojun; Chen, Minshan; Zhou, Zhongguo
免疫/内分泌
胆管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Dynamic changes of serum α-fetoprotein predict the prognosis of bevacizumab plus immunotherapy in hepatocellular carcinoma

血清甲胎蛋白的动态变化可预测贝伐珠单抗联合免疫疗法治疗肝细胞癌的预后

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000001860
Yang, Zhenyun; Fu, Yizhen; Wang, Qianyu; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study

比较乐伐替尼与贝伐单抗联合免疫检查点抑制剂和介入三联疗法治疗中国晚期肝细胞癌的疗效：CLEAP 2302 研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000545545
Pan, Zhaolong; Liu, Dongming; Cao, Junbo; Fu, Linlin; Zhang, Xihao; Zhu, Xiaodong; Pan, Yangxun; Liu, Jianwei; Han, Chuangye; Jin, Renan; Shen, Shunli; Zhang, Xiaoyun; Liu, Hongzhi; Yang, Xiaobo; Hu, Kuan; Shi, Xiaoyi; Wang, Dongxu; Zhao, Yang; Zhong, Jianhong; Xiang, Bangde; Gu, Shanzhi; Li, Tao; Zhang, Shuijun; Zhou, Ledu; Zhao, Haitao; Zeng, Yongyi; Wen, Tianfu; Kuang, Ming; Liang, Xiao; Peng, Tao; Wang, Kui; Xu, Li; Li, Huikai; Song, Tianqiang; Sun, Huichuan; Zhang, Wei
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes

单细胞分析揭示了2型糖尿病钻孔模型中骨膜细胞增殖受损的骨膜特征

期刊:Cell Communication and Signaling
影响因子:8.2
doi:10.1186/s12964-025-02349-y
Xing Ji # ，Jiahao Luo # ，Yangxun He ，Xinhua Hu ，Taotao Xu ，Yuanlong Wang ，Sijun Pan ，Jiali Yao ，Weiwei Hu # ，Ximei Wu #
代谢
细胞生物学
糖尿病
单细胞
发表日期：2025
文献求助 收藏

Estimation of Genetic Parameters for Carcass and Meat Quality Traits Using Genomic Information in Yorkshire Pigs

利用基因组信息估计约克郡猪胴体和肉质性状的遗传参数

期刊:Animals
影响因子:2.7
doi:10.3390/ani15142075
Zheng, Yangxun; Ma, Fuping; Zhao, Xitong; Liu, Yanling; Zou, Quan; Liu, Huatao; Li, Shujuan; Zhang, Zipeng; Yang, Sen; Xing, Kai; Wang, Chuduan; Ding, Xiangdong
发表日期：2025
文献求助 收藏

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

肿瘤周围肝细胞中的YTHDF2通过CX3CL1介导的CD8+ T细胞募集，介导化疗诱导的抗肿瘤免疫反应。

期刊:Molecular Cancer
影响因子:27.7
doi:10.1186/s12943-024-02097-6
Zhenyun Yang # ，Xin Wang # ，Yizhen Fu # ，Weijie Wu # ，Zili Hu ，Qingyang Lin ，Wei Peng ，Yangxun Pan ，Juncheng Wang ，Jinbin Chen ，Dandan Hu ，Zhongguo Zhou ，Li Xu ，Yaojun Zhang ，Jiajie Hou ，Minshan Chen
CX3CL1
免疫/内分泌
T细胞
肿瘤免疫
细胞生物学
肿瘤
T细胞
CD8
发表日期：2024
文献求助 收藏

Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm

对于直径≤5.0厘米的单发肝细胞癌，立体定向放射治疗是射频消融术的替代方案。

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2024.101151
Yang, Zhoutian; Liu, Shiliang; Hu, Li; Chen, Jinbin; Wang, Juncheng; Pan, Yangxun; Xu, Li; Liu, Mengzhong; Chen, Minshan; Xi, Mian; Zhang, Yaojun
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study

乐伐替尼联合帕博利珠单抗与一线全身化疗治疗晚期肝内胆管癌的比较：一项真实世界回顾性研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1494520
Yang, Zhenyun; Wu, Weijie; Hu, Zhiwen; Fu, Yizhen; Hu, Zili; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Zhou, Zhongguo; Zhang, Yaojun; Chen, Minshan; Hu, Dandan
肿瘤
胆管癌
肿瘤免疫
发表日期：2024
文献求助 收藏